Eric Crombez's Insider Trades & SAST Disclosures

Eric Crombez's most recent trade in Ultragenyx Pharmaceutical Inc. was a trade of 30,246 Stock Ooption (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 30,246 30,246 - - Stock Ooption (Right to Buy)
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 16,813 65,244 (0%) 0% 0 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 14,971 80,215 (0%) 0% 0 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Sale of securities on an exchange or to another person at price $ 42.10 per share. 01 Mar 2025 8,945 71,922 (0%) 0% 42.1 376,585 Common Stock
Abeona Therapeutics Inc
Eric Crombez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2025 36,101 47,145 (0%) 0% 0 Common Stock
Abeona Therapeutics Inc
Eric Crombez Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2024 11,044 11,044 (0%) 0% 0 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Sale of securities on an exchange or to another person at price $ 43.66 per share. 02 May 2024 354 48,431 (0%) 0% 43.7 15,456 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Sale of securities on an exchange or to another person at price $ 44.10 per share. 18 Apr 2024 142 48,785 (0%) 0% 44.1 6,262 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 34,200 34,200 - - Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 19,400 49,912 (0%) 0% 0 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 2,351 2,351 - - Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Sale of securities on an exchange or to another person at price $ 53.76 per share. 01 Mar 2024 1,238 48,927 (0%) 0% 53.8 66,555 Common Stock
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 8,362 8,362 - - Stock Option (Right to Buy)
Ultragenyx Pharmaceutical ...
Eric Crombez EVP and Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2023 4,658 30,512 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades